In vitro-induced antibody production in chronic hepatitis C virus infection

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 3, 2003, Pages 361-368

  Oloveira, E B ^a   Ferraz, M L G ^a   Perez, R M ^a   Silva, A E B ^a   Lanzoni, V P ^a   Granato, C F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti HCV antibodies; Hepatitis C; Hepatitis C virus RNA; In vitro induced antibody production; IVIAP; Liver biopsy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; AGED; ANTIBODY PRODUCTION; BIOCHEMISTRY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; GENDER; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LIVER CIRRHOSIS; LIVER INJURY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NON INVASIVE MEASUREMENT; PATHOGENESIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS LOAD;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0037358419     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2003000300011     Document Type: Review

References (20)

1. Lauer GM & Walker BD (2001). Hepatitis C virus infection. New England Journal of Medicine, 345: 41-52.
2. Sedgwick JD & Holt PG (1986). The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. Journal of Immunological Methods, 87: 37-44.
3. Amadori A, De Rossi A, Giaquinto C, Faulkner-Valle G, Zachello F & Chieco-Bianchi L (1988). In vitro production of HIV-specific antibody in children at risk of AIDS. Clinical Immunology and Immunopathology, 46: 342-351.
4. Ducos J, Bianchi-Mondain AM, François M, Boisset M, Vendrell JP, Baring F, Serre A & Larrey D (1994). Hepatitis C virus (HCV) - Specific in vitro antibody secretion by peripheral blood lymphocytes: correlation with progression of disease and HCV-RNA in HCV antibody positive patients. Journal of Clinical Microbiology, 32: 2613-2615.
5. Segondy M, Vendrell JP, Reynes J, Huguet MF, Albat B, Ducos J, Nicolas JC & Serre A (1990). Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infection. European Journal of Clinical Microbiology and Infectious Diseases, 9: 745-750.
6. Vendrell JP, Segondy M, Fournier AM, Huguet MF, Reynes J, Ducos J & Serre A (1991). Spontaneous in vitro secretion of antibody to cytomegalovirus (CMV) by human peripheral blood mononuclear cells: a new approach to studying the CMV-immune system interaction. Journal of Infectious Diseases, 164: 1-7.
7. Caterino-de-Araujo A, Santos-Fortuna E & Grumach AS (1991). An alternative method for in vitro production of HIV-specific antibodies. Brazilian Journal of Medical and Biological Research, 24: 797-799.
8. Ludwig J (1993). The nomenclature of chronic active hepatitis: an obituary. Gastroenterology, 105: 274-278.
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M & Scheuer P (1994). Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology, 19: 1513-1520.
10. Poynard T, Bedossa P & Opolon P (1997). Natural history of liver fibrosis progression in patients with chronic hepatitis C. The Obsvirc, Metavir, Clinivir and Dosvirc groups. Lancet, 349: 825-832.
11. Nishigushi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, Sakurai M, Shikata T & Yamamoto S (1991). Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology, 14: 985-989.
12. Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Nogushi O & Miyake S (1996). Hepatic iron contents and response to interferon-α, in patients with chronic hepatitis C. Digestive Diseases and Sciences, 41: 989-994.
13. Lohr HF, Gerken G, Roth M, Weyer S, Schlaak JF, Meyer ZUM & Buschenfelde KH (1998). The cellular immune response induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome. Journal of Hepatology, 29: 524-532.
14. Rehermann B & Chisari FV (2000). Cell mediated immune response to the hepatitis C virus. Current Topics in Microbiology and Immunology, 242: 299-325.
15. Popper HE & Schaffner F (1971). The vocabulary of chronic hepatitis. New England Journal of Medicine, 384: 1154-1157.
16. Teare JP, Sherman D, Greenfield SM, Simpson J, Bray G, Caterral AP, Murray-Lion IM, Peters TJ, Williams R & Thompson RP (1993). Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet, 342: 895-898.
17. Jenkins PJ, Cromie SL, Roberts SK, Finch CF & Dudley FJ (1996). Chronic hepatitis C, alcohol and hepatic fibrosis. Hepatology, 24: 153A (Abstract).
18. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Arase Y, Fukuda M, Chayama K, Murashima N & Kumada H (1998). Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. Journal of Hepatology, 28: 930-938.
19. Lindqvist U (1997). Is serum hyaluronan a helpful tool in the management of patients with liver diseases? Journal of Internal Medicine, 242: 67-71.
20. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y & Poynard T (2001). Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet, 357 1069-1075.